Experts link tamoxifen use to diabetes in breast cancer survivors

10/3/2011 | PhysiciansBriefing.com

A study of 14,360 early-stage breast cancer survivors showed that 10% of patients who had tamoxifen treatment developed diabetes during a mean follow-up time of 5.2 years. The findings suggest that tamoxifen may worsen an underlying diabetes risk in susceptible women, researchers reported in the journal Cancer.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA